Serious adverse events, some of which may require a second operation, can occur after the use of rhBMP-2 in oral and maxillofacial procedures.
In this analysis graft, failure and pseudarthrosis were more commonly reported after off-label uses of rhBMP-2 than approved uses.
2012-03-27
Eng.
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
US Food and Drug Administration, Rockville, MD, USA. jane.woo [at] fda.hhs.gov
J Oral Maxillofac Surg. 2012 Apr;70(4):765-7
© Galenicom 1999-2013